Helsinki Urological Cancer Center (HUCC) focuses around the clinical and academic work done at the HUS Helsinki University Hospital and Helsinki University

With our multidisciplinary approach, we explore new ways of prognosis and treatment for clinically significant prostate cancer. We explore RNA and protein expression of prostate cancer, finding new game-changing biomarkers. By using artificial intelligence, we create algorithms for cancer recognition in pathological H&E slides and MRI images, connecting this to patient data. We seek to translate our findings into clinical everyday practice and empower the future of precision medicine.

Our research